Klinische Wochenschrift

, Volume 64, Issue 24, pp 1291–1291 | Cite as

Long-term effects of nifedipine on plasma levels of 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D in hypertensive hemodialyzed patients

  • W. Riegel
  • W. H. Hörl
  • A. Heidland
Eilige Kurzmitteilung

Key words

25 Hydroxyvitamin D (25-OH-D) 1,25 Dihydroxyvitamin D (1,25-(OH)2-D) Nifedipine Regular Hemodialysis Therapy (RDT) 

References

  1. 1.
    Baran DT, Milne ML (1983) 1,25-dihydroxyvitamin D-induced inhibition of3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int 35:461–464PubMedGoogle Scholar
  2. 2.
    Baran DT, Milne ML (1986) 1,25 dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase. J Clin Invest 77:1622–1626PubMedGoogle Scholar
  3. 3.
    Goligorsky MS, Chaimovitz C, Shany S, Rapoport J, Sharony Y (1984) Verapamil improves defective intestinal calcium absorption in uremia. Adv Exp Med Biol 178:153–161PubMedGoogle Scholar
  4. 4.
    Resnick LM, Laragh JH (1985) Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy. Am J Cardiol 56:68H-74HPubMedGoogle Scholar
  5. 5.
    Riegel W, Hörl WH, Heidland A (1986) Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients. Klin Wochenschr 64:1124–1130PubMedGoogle Scholar
  6. 6.
    Scharla S, Schmidt-Gayk H, Reichel H, Mayer E (1984) A sensitive and simplified radioimmunoassay for 1,25 dihydroxyvitamin D3. Clin Chim Acta 142:325–338PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • W. Riegel
    • 1
  • W. H. Hörl
    • 1
  • A. Heidland
    • 2
  1. 1.Medizinische Klinik, Abteilung Innere Medizin IVUniversität FreiburgGermany
  2. 2.Medizinische Klinik, Nephrologische AbteilungUniversität WürzburgGermany

Personalised recommendations